{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:27:19Z","timestamp":1792189639341,"version":"4.4.0"},"reference-count":170,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100032752","name":"Laboratoires Th\u00e9a","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100032752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>Glaucoma, a leading cause of irreversible blindness, is primarily managed by lowering intraocular pressure, yet treatment remains limited by poor adherence, ocular surface toxicity, and systemic adverse effects. This review focuses specifically on treatment simplification strategies in topical glaucoma therapy, exploring the paradigm shift towards a \u201cLess is better\u201d approach in glaucoma care, with particular emphasis on the use of preservative -free formulations, lower active ingredient concentrations, and fixed combinations. These approaches aim to improve treatment tolerability, adherence, and clinical outcomes while minimizing toxicity, complexity, and environmental burden. Although barriers such as higher costs and limited long-term data remain, this new approach represents a patient-centred, sustainable, and clinically effective model for the future of glaucoma management.<\/jats:p>","DOI":"10.1177\/11206721261438585","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:31:16Z","timestamp":1776432676000},"page":"1155-1169","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Optimizing topical glaucoma treatment outcomes: When less is better. A review on the clinical benefits of reducing treatment burden in glaucoma management"],"prefix":"10.1177","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-2422","authenticated-orcid":false,"given":"Ronald Marinus Petrus Cornelis","family":"de Crom","sequence":"first","affiliation":[{"name":"Maastricht University Medical Centre+"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9960-7579","authenticated-orcid":false,"given":"Luis","family":"Abeg\u00e3o Pinto","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology. ULS Santa Maria, Lisbon, Portugal"},{"name":"Faculty of Medicine of Lisbon University, Lisbon, Portugal 6. Princess Alexandra Eye Pavilion and University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Stalmans","sequence":"additional","affiliation":[{"name":"University Hospitals UZ Leuven"},{"name":"Research Group Ophthalmology, Department of Neurosciences, Catholic University KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Tatham","sequence":"additional","affiliation":[{"name":"Princess Alexandra Eye Pavilion and University of Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Prokosch","sequence":"additional","affiliation":[{"name":"University Eye Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Kolko","sequence":"additional","affiliation":[{"name":"Aalborg University Hospital; Eye hospital Your Eye Doctors (Dine \u00d8jenl\u00e6ger), Sundhedshuset"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2010-1701","authenticated-orcid":false,"given":"Jose Manuel","family":"Benitez-del-Castillo","sequence":"additional","affiliation":[{"name":"Universidad Complutense, Ocumed-Clinica Rementeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"e_1_3_3_2_2","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study","volume":"9","author":"GBD 2019 Blindness and Vision Impairment Collaborators* and Vision Loss Expert Group of the Global Burden of Disease Study\u2020, on behalf of the","year":"2021","unstructured":"GBD 2019 Blindness and Vision Impairment Collaborators* and Vision Loss Expert Group of the Global Burden of Disease Study\u2020, on behalf of the. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health 2021; 9: e144\u2013e160.","journal-title":"Lancet Glob Health"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2025.06.002"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.05.013"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01289-8"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000001110"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1527319"},{"key":"e_1_3_3_8_2","first-page":"741","article-title":"Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension","volume":"4","author":"Lee AJ","year":"2010","unstructured":"Lee AJ, McCluskey P. Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension. Clin Ophthalmol 2010; 4: 741\u2013764.","journal-title":"Clin Ophthalmol"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.2165\/11634460-000000000-00000"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5090079"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6138132"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2025-egsguidelines"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-025-04378-0"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.10.022"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2016.1209481"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-022-00557-0"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14051587"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94574-x"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcto3010002"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1826928"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S176605"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2024.08.001"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering11101010"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2009.08.016"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.06.023"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2010.03.001"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-008-0078-y"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12131"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-96919-2"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.16728"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.002013"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2908310"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2021.03.010"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2024.101250"},{"key":"e_1_3_3_35_2","first-page":"1806","article-title":"Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells","volume":"17","author":"Ammar DA","year":"2011","unstructured":"Ammar DA, Kahook MY. Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells. Mol Vision 2011; 17: 1806\u20131813.","journal-title":"Mol Vision"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-14548"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050180"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.13814"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(11)70024-6"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0266"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000977"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000544"},{"key":"e_1_3_3_43_2","doi-asserted-by":"crossref","unstructured":"Dubrulle P Labb\u00e9 A Brasnu E et al. Influence of Treating Ocular Surface Disease on Intraocular Pressure in Glaucoma Patients Intolerant to Their Topical Treatments: A Report of 10 Cases - PubMed https:\/\/pubmed.ncbi.nlm.nih.gov\/30489502\/ (2018 accessed 18 July 2025).","DOI":"10.1097\/IJG.0000000000001041"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90116-1"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-025-01203-1"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31825af67d"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-021-00447-x"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100916"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S150816"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1177\/112067210701700311"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)88478-7"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2011.562340"},{"key":"e_1_3_3_53_2","first-page":"971","article-title":"The effect of varying dosing interval on the efficacy of intraocular pressure lowering drugs","volume":"45","author":"Serle JB","year":"2004","unstructured":"Serle JB, Toor A, Fahim MM, et al. The effect of varying dosing interval on the efficacy of intraocular pressure lowering drugs. Invest Ophthalmol Vis Sci 2004; 45: 971. https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2406778 (2004).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2018.0134"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogla.2025.10.003"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000000668"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14103"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2011.08.004"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200404000-00013"},{"key":"e_1_3_3_60_2","first-page":"1","article-title":"Considerations in glaucoma therapy: fixed combinations versus their component medications","volume":"4","author":"Higginbotham EJ","year":"2010","unstructured":"Higginbotham EJ. Considerations in glaucoma therapy: fixed combinations versus their component medications. Clin Ophthalmol 2010; 4: 1\u20139.","journal-title":"Clin Ophthalmol"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200724120-00004"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.6.714"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.10.1268"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00873-9"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2009.05.001"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.1.48"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2023-001607"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000270"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1177\/1120672118785280"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01731-9"},{"key":"e_1_3_3_71_2","first-page":"273","article-title":"Preservative-free versus preserved latanoprost eye drops for reducing intraocular pressure: a non-inferiority phase iii randomized, multi-center, single-blind, parallel-group controlled trial","volume":"9","author":"Theodosiadis P","year":"2020","unstructured":"Theodosiadis P, Konstas A, Halkiadakis I, et al. Preservative-free versus preserved latanoprost eye drops for reducing intraocular pressure: a non-inferiority phase iii randomized, multi-center, single-blind, parallel-group controlled trial. Med Hypothesis, Discov, Innov Ophthalmol 2020; 9: 273\u2013283.","journal-title":"Med Hypothesis, Discov, Innov Ophthalmol"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-303040"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2024.0092"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000002371"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31815a3472"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/804730"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2010.01907.x"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14926"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12261"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e3182a075e6"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2022.11.001"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-302121"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1177\/1120672117753703"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S264984"},{"key":"e_1_3_3_85_2","first-page":"821","article-title":"Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma","volume":"10","author":"Walimbe T","year":"2016","unstructured":"Walimbe T, Chelerkar V, Bhagat P, et al. Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma. Clin Ophthalmol (Auckland, N.Z.) 2016; 10: 821\u2013827. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L610312716&from=export (2016).","journal-title":"Clin Ophthalmol (Auckland, N.Z.)"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000000020"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2011.03.012"},{"key":"e_1_3_3_88_2","article-title":"A comparison of 0.1% timolol eye gel and 0.5% timolol eye drop in patients with chronic angle-closure glaucoma","volume":"95","author":"Metheetrairut A","year":"2012","unstructured":"Metheetrairut A, Leumsamran P, Rojananin S, et al. A comparison of 0.1% timolol eye gel and 0.5% timolol eye drop in patients with chronic angle-closure glaucoma. J Med Assoc Thai 2012; 95: S116\u2013S122.","journal-title":"J Med Assoc Thai"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1159\/000310682"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000006"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2005.00562.x"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2008.10.004"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1475-097X.2002.00430.x"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S137537"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.304"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.12.003"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-015-0392-2"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S59197"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214113"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-025-03342-0"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2003.00065.x"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2023.2197496"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2025-327555"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.972500"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-025-03411-x"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S462672"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2010.07.024"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e3181507313"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1177\/112067210701700108"},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2013(10)05"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1873947"},{"key":"e_1_3_3_112_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2013.815160"},{"key":"e_1_3_3_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30314-5"},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270011420254"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S106159"},{"key":"e_1_3_3_116_2","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200404000-00012"},{"key":"e_1_3_3_117_2","doi-asserted-by":"publisher","DOI":"10.1089\/108076803321637618"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000001"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-014-0168-y"},{"key":"e_1_3_3_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(02)00295-3"},{"key":"e_1_3_3_121_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2013.0229"},{"key":"e_1_3_3_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2016.12.002"},{"key":"e_1_3_3_123_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.018234"},{"key":"e_1_3_3_124_2","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S168921"},{"key":"e_1_3_3_125_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-021-01813-w"},{"key":"e_1_3_3_126_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093137"},{"key":"e_1_3_3_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0181-5512(08)74379-1"},{"key":"e_1_3_3_128_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079903125001820"},{"key":"e_1_3_3_129_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.9.6.1059"},{"key":"e_1_3_3_130_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2011.0057"},{"key":"e_1_3_3_131_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-012-0186-8"},{"key":"e_1_3_3_132_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S150595"},{"key":"e_1_3_3_133_2","doi-asserted-by":"publisher","DOI":"10.1177\/112067210901900411"},{"key":"e_1_3_3_134_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2021.0099"},{"key":"e_1_3_3_135_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01239-8"},{"key":"e_1_3_3_136_2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2011.134"},{"key":"e_1_3_3_137_2","first-page":"5022","article-title":"PASSY \u201cPatient satisfaction survey\u201d in glaucoma disease: Spanish results","volume":"56","author":"Roman S","year":"2015","unstructured":"Roman S. PASSY \u201cPatient satisfaction survey\u201d in glaucoma disease: Spanish results. Invest Ophthalmol Visual Sci 2015; 56: 5022. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L615920783&from=export (2015).","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_3_138_2","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S131853"},{"key":"e_1_3_3_139_2","doi-asserted-by":"publisher","DOI":"10.1159\/000356468"},{"key":"e_1_3_3_140_2","doi-asserted-by":"publisher","DOI":"10.4274\/tjo.galenos.2019.29000"},{"key":"e_1_3_3_141_2","first-page":"3026","article-title":"Patient satisfaction related to tolerance when treated with preservative-free latanoprost; results from the PASSY survey in six European countries","volume":"57","author":"Lemij HG","year":"2016","unstructured":"Lemij HG, Stalmans I, Erb C, et al. Patient satisfaction related to tolerance when treated with preservative-free latanoprost; results from the PASSY survey in six European countries. Invest Ophthalmol Visual Sci 2016; 57: 3026. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L616082259&from=export (2016).","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_3_142_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S126042"},{"key":"e_1_3_3_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.05.033"},{"key":"e_1_3_3_144_2","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2022.2041041"},{"key":"e_1_3_3_145_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S229815"},{"key":"e_1_3_3_146_2","first-page":"441","article-title":"A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma","volume":"6","author":"Garcia-Feijoo J","year":"2012","unstructured":"Garcia-Feijoo J, Sampaolesi JR. A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma. Clin Ophthalmol 2012; 6: 441\u2013446.","journal-title":"Clin Ophthalmol"},{"key":"e_1_3_3_147_2","doi-asserted-by":"publisher","DOI":"10.4274\/tjo.galenos.2021.20726"},{"key":"e_1_3_3_148_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-005-0945-2"},{"key":"e_1_3_3_149_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.01.011"},{"key":"e_1_3_3_150_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903260129"},{"key":"e_1_3_3_151_2","doi-asserted-by":"publisher","DOI":"10.1080\/10643389.2021.1889284"},{"key":"e_1_3_3_152_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-025-05299-6"},{"key":"e_1_3_3_153_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2023.11.053"},{"key":"e_1_3_3_154_2","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31824ea491"},{"key":"e_1_3_3_155_2","doi-asserted-by":"publisher","DOI":"10.3129\/i08-076"},{"key":"e_1_3_3_156_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.scp.2016.07.001"},{"key":"e_1_3_3_157_2","doi-asserted-by":"publisher","DOI":"10.1177\/112067210801800519"},{"key":"e_1_3_3_158_2","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14491"},{"key":"e_1_3_3_159_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2005.00641.x"},{"key":"e_1_3_3_160_2","doi-asserted-by":"publisher","DOI":"10.2165\/0002512-200926020-00008"},{"key":"e_1_3_3_161_2","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001728"},{"key":"e_1_3_3_162_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2013.815159"},{"key":"e_1_3_3_163_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0656-z"},{"key":"e_1_3_3_164_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1098-3015(11)72642-0"},{"key":"e_1_3_3_165_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-311544"},{"key":"e_1_3_3_166_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2008.08.011"},{"key":"e_1_3_3_167_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-310877"},{"key":"e_1_3_3_168_2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.267"},{"key":"e_1_3_3_169_2","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1931123"},{"key":"e_1_3_3_170_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2023.05.012"},{"key":"e_1_3_3_171_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104473"}],"container-title":["European Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721261438585","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11206721261438585","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721261438585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:24:47Z","timestamp":1787649887000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11206721261438585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":170,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/11206721261438585"],"URL":"https:\/\/doi.org\/10.1177\/11206721261438585","relation":{},"ISSN":["1120-6721","1724-6016"],"issn-type":[{"value":"1120-6721","type":"print"},{"value":"1724-6016","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]}}}